Clinical Research Unit, Khoo Teck Puat Hospital, Singapore.
Clinical Research Unit, Khoo Teck Puat Hospital, Singapore; Diabetes Centre, Admiralty Medical Centre, Khoo Teck Puat Hospital, Singapore.
Diabetes Res Clin Pract. 2019 Nov;157:107812. doi: 10.1016/j.diabres.2019.107812. Epub 2019 Aug 8.
Increased adiposity confers elevated risk for diabetic kidney disease (DKD) progression in type 2 diabetes mellitus (T2DM). This 3-year prospective study examined whether worsening of metabolic control e.g. development of uncontrolled diabetes mediated the relationship between increased adiposity and DKD deterioration.
T2DM subjects who had adequately controlled diabetes (HbA1c < 8%) at initial recruitment were analysed (N = 853). HbA1c ≥ 8% at follow-up was classified as development of uncontrolled T2DM. Absolute changes in body weight (ΔWeight), body mass index (ΔBMI), and body fat mass (ΔBFM) were calculated by subtracting baseline from follow-up values. DKD deterioration (outcome) was defined as an increase in the composite ranking of relative risk by glomerular filtration rate and albuminuria levels (Kidney Disease: Improving Global Outcomes 2009).
Subjects with deteriorated DKD displayed lower reduction in body composition at follow-up than those who remained stable or/improved (all P < 0.05). In separate regression models, ΔWeight (risk ratio (RR):1.04, 95% CI:1.01-1.06), ΔBMI (RR:1.07, 95% CI:1.01-1.13), and ΔBFM (RR:1.03, 95% CI:1.01-1.06) were independently associated with worsened DKD. The associations were attenuated after accounting for the loss of glycaemic control. Binary mediation analysis revealed that the development of uncontrolled diabetes explained 41.7%, 45.4% and 39.7%, respectively, of the effects of ΔWeight, ΔBMI and ΔBFM on the outcome.
Among T2DM individuals who had adequately-controlled T2DM at initial recruitment, the relationship between gain in adiposity and DKD deterioration is mediated by the development of poor glycaemic control over time. Therefore, preventing worsening adiposity and hyperglycaemia is pivotal to impede DKD progression.
肥胖会增加 2 型糖尿病(T2DM)患者发生糖尿病肾脏疾病(DKD)的风险。本前瞻性研究观察了代谢控制的恶化(如未控制的糖尿病的发展)是否介导了肥胖增加与 DKD 恶化之间的关系。
分析了在初始招募时已充分控制糖尿病(HbA1c<8%)的 T2DM 患者(N=853)。随访时 HbA1c≥8%被归类为未控制的 T2DM 的发展。通过从随访值中减去基线值来计算体重(ΔWeight)、体重指数(ΔBMI)和体脂肪量(ΔBFM)的绝对变化。DKD 恶化(结局)定义为肾小球滤过率和蛋白尿水平的复合风险排序增加(肾脏病:改善全球结果 2009)。
与稳定或改善的患者相比,DKD 恶化的患者在随访时身体成分的减少幅度更低(均 P<0.05)。在单独的回归模型中,ΔWeight(风险比(RR):1.04,95%置信区间(CI):1.01-1.06)、ΔBMI(RR:1.07,95%CI:1.01-1.13)和ΔBFM(RR:1.03,95%CI:1.01-1.06)与 DKD 恶化独立相关。在考虑到血糖控制的丧失后,这些关联减弱。二分中介分析显示,未控制的糖尿病的发展分别解释了ΔWeight、ΔBMI 和ΔBFM 对结局影响的 41.7%、45.4%和 39.7%。
在初始招募时已充分控制 T2DM 的 T2DM 个体中,肥胖增加与 DKD 恶化之间的关系是由随时间推移血糖控制恶化介导的。因此,预防肥胖和高血糖的恶化对于阻止 DKD 的进展至关重要。